The alliance between Eastman Kodak of Rochester, NY, and ATL ofBothell, WA, is finally ready to bear fruit. The firms next monthwill begin shipping the first components that allow their respectiveimage management systems to be connected to each other.
The alliance between Eastman Kodak of Rochester, NY, and ATL ofBothell, WA, is finally ready to bear fruit. The firms next monthwill begin shipping the first components that allow their respectiveimage management systems to be connected to each other.
Kodak and ATL announced in 1994 that they would collaborateto integrate ATL's Access ultrasound image management system withKodak's Digital Science PACS line (SCAN 2/1/95). Commerciallyavailable connections between the systems have been on hold, however,until Kodak completed work on the DICOM versions of its DigitalScience medical printer interface unit and Digital Science modalityacquisition unit, which acquire ultrasound images.
The units will begin shipping next month and will allow usersto send and retrieve color or gray-scale images between a KodakPACS and an Access workstation. Components for the integratedKodak/ATL system are available from either company.
In other news, Kodak has set a release date in the fourth quarterof this year for a new Digital Science workstation for digitalarchiving and off-line review of cardiac cath lab studies. Theworkstation uses CD-R (compact disk-recordable) media as an alternativefor cine film. The system, which consists of a CAS 6000 archivestation and a CRS 2000 review station, received 510(k) clearanceearlier this year.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.